Oncology & Hematology Coding Alert

Reader Questions:

Question Use of QV and QR

Question: The new oncology demonstration project includes a code for clinical trials. Do I need to append a demonstration project modifier to this code?


Florida Subscriber
Answer: You-re unlikely to need to append modifier QV (Item or service provided as routine care in a Medicare qualifying clinical trial) to demonstration project code G9057 (Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial). But you may need to append QV or QR (Item or service provided in a Medicare specified study) to the patient visit code, administration code, or other code to avoid an audit.

Example: Append QR to J8520 (Capecitabine, oral, 150 mg) when the patient receives the medication as part of a clinical trial for oral drugs fighting colorectal cancer. (See Medlearn Matters MM3742 at www.new.cms.hhs.gov/MedlearnMattersArticles/downloads/MM3742.pdf.)

Check out CMS- Clinical Trial page for all the details at www.cms.hhs.gov/ClinicalTrialPolicies/.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All